Designing inhibitors against fructose 1,6-bisphosphatase: Exploring natural products for novel inhibitor scaffolds
- 30 April 2010
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 45 (4), 1478-1484
- https://doi.org/10.1016/j.ejmech.2009.12.055
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetesProceedings of the National Academy of Sciences of the United States of America, 2005
- The evolving role of natural products in drug discoveryNature Reviews Drug Discovery, 2005
- Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?Journal of Medicinal Chemistry, 1998
- Evidence for an active T‐state pig kidney fructose 1,6‐bisphosphatase: Interface residue Lys‐42 is important for allosteric inhibition and AMP cooperativityProtein Science, 1996
- Pharmacokinetics, Metabolism and Toxicity of the Plant‐Derived Photoxin α‐TerthienylBasic & Clinical Pharmacology & Toxicology, 1995
- LIGPLOT: a program to generate schematic diagrams of protein-ligand interactionsProtein Engineering, Design and Selection, 1995
- The allosteric site of human liver fructose-1,6-bisphosphatase. Analysis of six AMP site mutants based on the crystal structure.Journal of Biological Chemistry, 1994
- Conformational transition of fructose-1,6-bisphosphatase: structure comparison between the AMP complex (T form) and the fructose 6-phosphate complex (R form)Biochemistry, 1991
- Fructose 2,6‐BisphosphatePublished by Wiley ,1987
- Regulation of Fructose‐Bisphosphatase ActivityPublished by Wiley ,1983